2022 ACSoMP recommendations
14 – 16 June 2022, WHO
Overview
An integrated WHO Pharmacovigilance team was established in 2020, to combine work related to the safety of medicines and vaccines within the Department of Regulation and Prequalification (RPQ). Following this transformation, WHO convened a joint meeting of the Advisory Committee on Safety of Medicinal Products (ACSoMP) and the Global Advisory Committee on Vaccine Safety (GACVS) for the first time on 14–16 June 2022. A summary of the presentations and recommendations from the medicines-specific sessions and from the sessions of common interest for the pharmacovigilance of medicines and vaccines is provided below.
The medicines-specific sessions were co-chaired by Dr June Raine from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and Dr Gerald Dal Pan from the United States Food and Drug Administration (US FDA) and sessions common to both vaccines and medicines were co-chaired by Dr Dure Samin Akram from the Health, Education and Literacy Program in Pakistan and Dr Gerald Dal Pan.